The American Red Cross reported a severe shortage of blood that has affected Tri-City area hospitals. In the last month, there has been a 35% drop in blood supply. The 'Code Red' blood shortage in Washington created a critical situation with hospitals requesting for blood. The drop is also noted due to the winter weather that has affected donation drive.

Red Cross Faces Blood Shortage: How Does Weather Influence Blood Bank?

Reports note that during the winter season, blood supply becomes challenging, though its demand may increase due to illness and severe weather conditions. However, the same factors lead to fewer donation drives that leads to critical shortage. According to Red Cross reports, more than 550 blood drives have been canceled since January 21. This has resulted in over 15,000 uncollected blood and platelet donation.

The shortage has severely impacted the availability of blood for trauma victims, cancer patients and those who require emergency surgeries. During such situation, volunteer donors play an essential role.

Diana Heilman, supervisor at the Kennewick Red Cross Fixed Site, said, "octors may face difficult decisions during a blood shortage, such as who can safely receive the products and treatments, and they will potentially have to wait because there simply isn't enough blood available."

Red Cross Faces Blood Shortage: What Is Affected?

• The Kennewick Red Cross identified a dire need of Type O blood, both positive and negative
• A negative
• B negative
• Platelets

Type O is a universal donor, while Type O positive is the most commonly transfused blood type. A negative blood type is found in only 6% of the population, and B negative is less than 2%.

Red Cross also announced a $20 e-gift card for those who donate between January 26 to February 28, as incentive.

Read: Japan Races To Develop World’s First Artificial Blood, Trials To Begin

Red Cross Faces Blood Shortage: Who Can Donate?

Must be in good general health, weigh at least 110 pounds, and be 17 years old (or 16 with parental consent where permitted)

• Valid identification is required, along with a brief health screening before donation
• Minimum hemoglobin levels: 12.5 g/dL for women and 13.0 g/dL for men
• Most medications are allowed, but blood thinners and some antiviral drugs may disqualify donors
• The full donation visit takes about one hour; the actual blood draw lasts 8–10 minutes
• Whole blood can be donated every 56 days; Power Red donations every 112 days
• Platelets are in high demand due to their five-day shelf life and essential role in cancer, trauma, and surgical care
• Donors with O negative, O positive, A negative, and B negative blood types are encouraged to consider Power Red donations
• Officials urge eligible donors to schedule appointments promptly to help address ongoing blood shortages impacting patient care

Red Cross Faces Blood Shortage: Frequently Asked Questions

Read: Thinking of Donating Blood? A Doctor Answers All Your Doubts

Can Women Donate Blood During Their Period?

This is one of the most common concerns, especially among first-time female donors. According to Dr. Sangeeta Pathak, Director and Head of Transfusion Medicine at Max Super Speciality Hospital, Saket, who spoke to Health and Me, as per the Drugs and Cosmetics Act, women are advised not to donate during their menstruation, particularly during the 4-5 days of active bleeding. However, they are completely eligible to donate at any other time of the month if they are in good health.

Can You Donate Blood While Recovering From An Illness?

Health is key when it comes to blood donation. “A person should be completely healthy and free from fever or illness at the time of donation,” says Dr. Pathak. Moreover, certain medications can lead to deferral, and there is a comprehensive list maintained under the Drugs and Cosmetics Act. So if you’re on a prescribed course, it’s best to consult a doctor or the blood bank before donating.

Can You Donate Blood If You Have A Tattoo Or Piercing?

Yes. If you’ve recently had a tattoo or body piercing, you’ll need to wait 12 months before you can donate blood. This is a precautionary step to ensure there’s no risk of transmitting infections.

Cancer, a rare occurrence? Unfortunately, not anymore. According to recent findings from an analysis published in The Lancet, cancer is one of the top 10 causes of death among Indian children. This is an alarming statistic, signalling an under-recognised public health problem. Data in the Global Burden of Disease Study 2023 noted that even as infectious diseases decline, noncommunicable diseases like cancer are emerging as a serious threat to child survival and well-being. In India, this epidemiological shift is particularly concerning in the context of childhood cancers. Despite being rare, they are highly treatable when detected in the early stages—yet most cases are diagnosed late.

As per the Indian Council of Medical Research’s National Centre for Disease Informatics and Research (ICMR-NCDIR), childhood cancers accounted for 3–5 per cent of cancer cases reported in India in 2022. The country sees an estimated 50,000 to 60,000 cases every year among children aged 0–14 years. This makes it one of the highest burdens globally. In 2023, 377,000 cases of childhood cancer were reported globally, along with 144,000 deaths, according to The Lancet research paper.

Read more: 3 Children In Every 4 Minutes Are Diagnosed With Cancer, That's What Makes Awareness Important Says Doctor

Hidden cancer burden in India

When it comes to childhood cancers in India, leukaemia, or blood cancers, are the most common, followed by lymphomas and tumours of the central nervous system. Collectively, these categories comprise most cases of childhood cancers in the country. The statistics vary across regions, with Delhi reporting the highest number of cases due to better diagnostic facilities. However, experts believe that the actual burden is likely to be much higher. Incomplete cancer registration and limited access to proper diagnostic facilities in underserved and rural areas are to blame for delayed diagnosis.

Why is childhood cancer detected late in India?

Experts say that cancer deaths in India can largely be attributed to delayed diagnosis. Early symptoms of cancer in children include fatigue, fever, unexplained weight loss, and swelling in certain body parts. These symptoms are often overlooked, leading to delays at multiple levels. According to the ICMR 2022 factsheet, a significant proportion of children reach hospitals only at advanced stages of the disease. By then, treatment becomes more complex, more expensive, and less likely to succeed.

Access to cancer care for children

Access to cancer care for children is uneven in India. Paediatric oncology services are largely limited to hospitals in tier-one cities, forcing families from rural areas and smaller towns to travel in order to access proper treatment. This imbalance results in delayed care, especially for economically vulnerable families. Financial limitations are another barrier in the process—even if treatment costs are subsidised, expenses such as travel, accommodation, and loss of income can be overwhelming.

Read more: 41 million children aged 5-19 living with high BMI in India: Study

Irregular survival patterns

Globally, survival rates for childhood cancers exceed 80 per cent in high-income countries. In India, outcomes are uneven. The ICMR 2022 factsheet noted that survival depends on the stage of diagnosis, type of cancer, and where the child is treated. Hospitals in India are reporting improving survival rates for certain forms of cancer, such as acute lymphoblastic leukaemia. The ICMR factsheet also highlights the need for a dedicated approach to paediatric cancer care, including better infrastructure, trained doctors, and stronger referral systems.

Indian weddings are a global sensation for all the taam-jhaam—the outfits, the music, the madness, and the unmatched vibe. In an ever-evolving culture, several new trends become a part of the wedding buzz in India. At a time when weight-loss drugs are the talk of the town, it is no surprise that they, too, have joined the list of new must-haves for Indian brides. For many soon-to-be brides and grooms, the pressure to look a class apart is always high. Amid the madness of wedding preparations, brides and grooms often miss the gym—weight-loss drugs come to their rescue.

India's Mounjaro brides

Clinics in metropolitan cities like Delhi and Mumbai are introducing weight-loss treatments into their traditional pre-bridal and bridal packages. Bridal packages initially focused on hair care, skincare, hair styling, and grooming—but they have now expanded to include shots of Mounjaro, a popular weight-loss drug. Some wellness centres in the city have advertised that they offer customised programmes combining workout routines, nutrition, and medication to help clients achieve desired results.

Doctors have noticed a clear rise in such inquiries. Several specialists report that a significant portion of their patients seeking obesity treatments are engaged couples working within a fixed timeline. While medical professionals acknowledge this demand, many emphasise that such treatments should only be prescribed when medically appropriate, rather than purely for cosmetic reasons.

Read more: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype

The pressures of looking good at a wedding

Weddings in India are deeply rooted in tradition, elaborate, and often burdened by societal expectations around appearance. As a result, many resort to glycolic treatments, injections of Mounjaro, and sometimes even facial procedures for a bridal glow. However, weight-loss drugs serve a different purpose—they can boost a bride's confidence by helping her feel more comfortable in her own skin.

Others share similar experiences. Some individuals admitted that concerns about body image, often influenced by family expectations or societal standards, played a major role in their decision. In certain cases, weight became a factor in arranged marriage discussions, pushing individuals to seek faster solutions. However, most discontinued the injections shortly after their weddings.

Why are weight-loss drugs becoming so popular?

According to experts, the growing popularity of weight-loss drugs is linked to their increased availability. Globally, pharmaceutical companies have introduced their own versions of obesity treatments in India, and demand has risen drastically. At the same time, more affordable alternatives are being introduced by manufacturers to make these drugs accessible to a wider audience.

A word of caution

Despite the surge, experts warrant caution. Weight-loss drugs are intended to help clinically obese or significantly overweight individuals, as well as patients with type 2 diabetes and hypertension. These drugs are not meant to act as quick fixes for short-term aesthetic goals. Experts, therefore, stress the importance of using these drugs under expert guidance and supervision.

Misuse of weight-loss drugs

Doctors are also concerned about the misuse of weight-loss drugs—health authorities have started monitoring the sale and promotion of such medication, especially the cheaper versions on the market. Experts say that relying solely on these drugs instead of making essential lifestyle changes may not lead to sustainable results. For many, the appeal lies in convenience—maximum benefits with minimal effort. While these drugs may fit into a hectic routine, doctors continue to emphasise the need for a balanced approach to weight loss.

The UK National Health Service (NHS) is soon expected to roll out free weight-loss Wegovy jab to over a million people in England at risk of heart attacks and strokes.

The move is based on the recommendation of the National Institute for Health and Care Excellence (NICE), which said that overweight people with heart problems, or serious circulation problems in their legs, should have the weekly jab "as an extra layer of protection".

Developed by Danish drugmaker Novo Nordisk, Wegovy is primarily an antidiabetic medication used to treat Type 2 diabetes. People receiving the weight-loss drug Wegovy sustained weight loss for up to four years.

"We know that people who have already had a heart attack or stroke are living with real fear that it could happen again. The evidence from the clinical trial is compelling. It showed that people taking semaglutide alongside their existing heart medicines were significantly less likely to have another heart attack or stroke,” said Helen Knight, from NICE.

"Today's decision gives thousands of people in that situation an extra layer of protection, on top of the medicines they are already taking," she added.

Also read: Foundayo: US FDA Approves Eli Lilly’s GLP-1 Weight Loss Pill

Wegovy and Heart Risk

A November 2023 study, published in the New England Journal of Medicine, elicited a randomized clinical trial of tens of thousands of people, in which Wegovy - alongside existing heart medicines - was linked to a 20% reduced risk of heart attacks and strokes.

Importantly, benefits were seen early in the clinical trial, before significant weight loss occurred, suggesting the drug works directly on the heart and blood vessels, not just through weight loss, as per the NICE

The BBC reported that the UK faces a significant heart disease burden, and every year:

100,000 people get hospitalized due to heart attacks,

100,000 people experience a stroke

350,000 people live with peripheral arterial disease.

Sharon Hodgson, the health minister, said weight-loss drugs were a “gamechanger” and giving them to people at risk of heart attacks and strokes would be a “lifesaver”.

Also read: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype

Wegovy Is Top Weight-Loss Choice for US Teens

Only Wegovy has been approved by the US FDA for children aged 12 and older who are living with obesity. Since the approval in late 2022, the prescriptions have surged.

According to health data company Truveta, which reviewed medical records from 30 US health systems, prescriptions for Wegovy among teens jumped by 50 percent in 2024—rising from 9.9 per 100,000 adolescents in 2023 to 14.8 per 100,000 in 2024.

The first quarter of 2025 showed another increase, with the rate reaching 17.3 per 100,000.